KC5-14547-87894
4 vaccinations
10 coded responses
37 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 117 / NY
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-02
Dose 1 — Pfizer-BioNTech
-
2021-01-03
Registered in v-safe
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-03
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
-
2021-01-24
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Sensitive skin, Skin sensitisation — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Abdominal painFree text: Skin sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Skin sensitisation — Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Skin sensitivity and loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Oral herpes — Feeling: Good · HeadacheFree text: Cold sore/fever blister developingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Oral herpes — Feeling: GoodFree text: Cold sore/fever blisterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Oral herpes — Feeling: GoodFree text: Cold sore/fever blisterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
-
2021-04-25
Survey response — 3 months, dose 2MedDRA: Hypersensitivity, Nasal congestion, Oral herpes, Respiratory tract congestion — Feeling: GoodFree text: Multiple cold sores. Worsened allergy symptoms (stuffy nose, congestion)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-25
-
2021-12-11
Dose 3 — Pfizer-BioNTech
-
2022-01-24
Survey response — 12 months, dose 2MedDRA: Pregnancy, Upper respiratory tract infection — Feeling: GoodFree text: Multiple upper respiratory infections. PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-06-11
-
2022-10-10
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-12
Survey response — days 1–6 daily, dose 4MedDRA: Unevaluable event — Feeling: Good · Site: Swelling, Itching · HeadacheFree text: Started mensesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
-
2022-10-15
Survey response — days 1–6 daily, dose 4MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-16
- 2022-10-19
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-16
-
2022-11-21
Survey response — day 42, dose 4MedDRA: Cough, Headache, Nasal congestion, Oropharyngeal pain, Respiratory symptom, Respiratory tract congestion — Feeling: FairFree text: Frequent headaches, upper respiratory illness (congestion, stuffy nose, cough, sore throat)MedDRA releases: 2024-11 · check-in free text available
- 2023-01-09
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-24 | Pfizer-BioNTech | |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
| 4 | 2022-10-10 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Skin sensitivity
Systemic reaction (other): Skin sensitivity and loss of appetite
Systemic reaction (other): Cold sore/fever blister developing
Systemic reaction (other): Cold sore/fever blister
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Cold sore/fever blister
Release 7 — 3 months, dose 2
Symptoms: Multiple cold sores. Worsened allergy symptoms (stuffy nose, congestion)
Release 11 — 12 months, dose 2
Symptoms: Multiple upper respiratory infections. Pregnancy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Started menses
Systemic reaction (other): Runny nose
Release 12 — day 42, dose 4
Symptoms: Frequent headaches, upper respiratory illness (congestion, stuffy nose, cough, sore throat)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Oral herpes | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sensitive skin | · | · | ✓ |
| SRO | Skin sensitisation | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release